Canada markets closed

Filament Health Corp. (FLHLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0450-0.0050 (-10.00%)
At close: 02:54PM EDT

Filament Health Corp.

2900 – 550 Burrard Street
Vancouver, BC V6C 0A3

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees11

Key Executives

NameTitlePayExercisedYear Born
Mr. Benjamin LightburnCo-Founder, CEO & Chairman126.77kN/A1987
Mr. Tom KineshankoCo-Founder126.77kN/A1985
Mr. Warren Duncan CPAChief Financial Officer108.66kN/A1991
Mr. Jon ConlinCorp. Sec. & DirectorN/AN/A1986
Ms. Lisa RankenChief Operating OfficerN/AN/A1984
Mr. Ryan MossChief Science OfficerN/AN/AN/A
Ms. Anna CordonDirector of CommunicationsN/AN/AN/A
Mr. Jeff FellowsHead of RegulatoryN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.

Corporate Governance

Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.